February 2, 2024

Balchem Announces Conference Call for Fourth Quarter 2023 Financial Results

Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, February 16, 2024, at 11:00 AM Eastern Time (ET) to review 4th Quarter 2023 financial results.
December 15, 2023

Balchem Named on Newsweek’s 2024 List of America’s Most Responsible Companies

Balchem named one of America's Most Responsible Companies by Newsweek magazine for the fourth consecutive year.
February 10, 2023

Balchem Announces Conference Call for Fourth Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 24th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2022 results.
January 6, 2023

Balchem Corporation Named on Newsweek’s 2023 List of America’s Most Responsible Companies

Balchem named one of America's Most Responsible Companies by Newsweek magazine for the third consecutive year.
October 21, 2022

Balchem Announces Conference Call for Third Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, November 4th at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2022 results.
August 30, 2022

Balchem Corporation Acquires Bergstrom Nutrition

Balchem Corporation is excited to announce the acquisition of Cardinal Associates Inc., operating as “Bergstrom Nutrition,” a leading science-based manufacturer of methylsulfonylmethane (MSM), based in Vancouver, Washington.
July 15, 2022

Balchem Announces Conference Call for Second Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, July 29th at 11:00 AM Eastern Time (ET) to review 2nd Quarter 2022 results.
June 21, 2022

Balchem Corporation Completes Acquisition of Kappa Bioscience AS

We are excited to announce that we completed our acquisition of Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
June 14, 2022

Balchem Corporation Signs Definitive Agreement to Acquire Kappa Bioscience AS

Balchem has signed a definitive agreement to acquire Kappa Bioscience AS, a leading science-based manufacturer of specialty vitamin K2 for the human nutrition industry, headquartered in Oslo, Norway.
April 22, 2022

Balchem Releases 2021 Sustainability Report

Balchem Corporation today released its 2021 Sustainability Report, which captures the Company's commitment to managing our Environmental, Social and Governance (ESG) performance.
April 15, 2022

Balchem Announces Conference Call for First Quarter 2022 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 29th at 11:00 AM Eastern Time (ET) to review 1st Quarter 2022 results.
February 4, 2022

Balchem Announces Conference Call for 4th Quarter 2021 Financial Results

Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 18th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2021 results.
1 2 3 7
Page 1 of 7